Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Lancet (London, England)
|
October 26, 1985
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia
S H Ralston, M D Gardner, F J Dryburgh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1977
Bone scan findings in hypervitaminosis D: case report
I Fogelman, J H McKillop, E A Cowden, et al.
Nuclear Medicine Communications
|
September 1, 1991
Augmentation of parathyroid 201Tl/99Tcm scanning by infusion of trisodium edetate
S J Gallacher, W D Fraser, F C Logue, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1972
The acute renal tubular effects of 1,25-dihydroxycholecalciferol
J B Puschett, P C Fernandez, I T Boyle, et al.
The Quarterly Journal of Medicine
|
March 1, 1986
Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour
S H Ralston, B F Boyce, R A Cowan, et al.
Clinical Endocrinology
|
December 1, 1977
1alpha-hydroxyvitamin D3 in primary hyperparathyroidism
I T Boyle, I Fogelman, B Boyce, et al.
The Journal of Biological Chemistry
|
October 10, 1973
1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine
M F Holick, A Kleiner-Bossaller, H K Schnoes, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1989
Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy
S H Ralston, B F Boyce, R A Cowan, et al.
Postgraduate Medical Journal
|
May 1, 1993
A comparison of 10 MHz ultrasound and 201-thallium/99m-technetium subtraction scanning in primary hyperparathyroidism
S J Gallacher, P Kelly, J Shand, et al.
The Quarterly Journal of Medicine
|
October 1, 1988
Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia
S H Ralston, A A Alzaid, S J Gallacher, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Lancet (London, England)
|
October 26, 1985
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia
S H Ralston, M D Gardner, F J Dryburgh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1977
Bone scan findings in hypervitaminosis D: case report
I Fogelman, J H McKillop, E A Cowden, et al.
Nuclear Medicine Communications
|
September 1, 1991
Augmentation of parathyroid 201Tl/99Tcm scanning by infusion of trisodium edetate
S J Gallacher, W D Fraser, F C Logue, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1972
The acute renal tubular effects of 1,25-dihydroxycholecalciferol
J B Puschett, P C Fernandez, I T Boyle, et al.
The Quarterly Journal of Medicine
|
March 1, 1986
Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour
S H Ralston, B F Boyce, R A Cowan, et al.
Clinical Endocrinology
|
December 1, 1977
1alpha-hydroxyvitamin D3 in primary hyperparathyroidism
I T Boyle, I Fogelman, B Boyce, et al.
The Journal of Biological Chemistry
|
October 10, 1973
1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine
M F Holick, A Kleiner-Bossaller, H K Schnoes, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 1, 1989
Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy
S H Ralston, B F Boyce, R A Cowan, et al.
Postgraduate Medical Journal
|
May 1, 1993
A comparison of 10 MHz ultrasound and 201-thallium/99m-technetium subtraction scanning in primary hyperparathyroidism
S J Gallacher, P Kelly, J Shand, et al.
The Quarterly Journal of Medicine
|
October 1, 1988
Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia
S H Ralston, A A Alzaid, S J Gallacher, et al.
Page
of 12